Percheron Therapeutics Management
Management criteria checks 2/4
Percheron Therapeutics' CEO is James Garner, appointed in Aug 2023, has a tenure of less than a year. directly owns 0.11% of the company’s shares, worth $56.89K. The average tenure of the management team and the board of directors is 2.1 years and 2.4 years respectively.
Key information
James Garner
Chief executive officer
AU$33.8k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.1% |
| Management average tenure | 2.1yrs |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
CEO
James Garner (50 yo)
less than a year
Tenure
AU$33,804
Compensation
Dr. James Garner, MA, MBA, MBBS, BSC (Hons), MAICD, serves as Non-Executive Director at Percheron Therapeutics Limited (formerly known as Antisense Therapeutics Limited) since May 08, 2023 and has been its...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | less than a year | AU$33.80k | 0.11% A$ 56.9k | |
| Chief Operating Officer | 1.2yrs | AU$463.17k | no data | |
| CFO & Joint Company Secretary | 17.3yrs | no data | no data | |
| Joint Company Secretary | 3.1yrs | no data | no data |
2.1yrs
Average Tenure
Experienced Management: ATHJ.F's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | less than a year | AU$33.80k | 0.11% A$ 56.9k | |
| Independent Non-Executive Director | 2.4yrs | AU$92.02k | 0.11% A$ 56.9k | |
| Independent Non-Executive Chair | 3yrs | AU$159.26k | 0.081% A$ 41.7k |
2.4yrs
Average Tenure
Experienced Board: ATHJ.F's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.